Table 1.
Typical (n=39) | Atypical (n=27) | p | |
---|---|---|---|
Age/years | 59 ± 14 | 58 ± 15 | NS |
AFL CL/ms | 247 ± 31 | 284 ± 48 | < 0.01 |
Ventricular CL/ms | 618 ± 201 | 655 ± 220 | NS |
Atrio:Ventricular ratio | 2.5 ± 0.8 | 2.3 ± 0.7 | NS |
LA diameter/mm | 39 ± 9 | 44 ± 7 | NS |
LVEF/% | 58 ± 17 | 55 ± 12 | NS |
NYHA Class ≥ II | 0 | 3 | NS |
Prior Cardiac Surgery | 6 | 12 | < 0.01 |
Medications | |||
Anti-arrhythmic* | 22 | 9 | NS |
Rate-slowing† | 25 | 12 | NS |
Hypertension | 18 | 8 | NS |
Diabetes Mellitus | 7 | 4 | NS |
Key: CL, Cycle length; LA, Left atrial; LVEF, Left ventricular ejection fraction; NYHA, New York Heart Association Heart Failure Class;
Therapy with class I or class III agents;
Therapy with β-blocker or calcium antagonists.